ACLX Arcellx Corp: רווח נקי למניה אחת בשנים עשר החודשים האחרונים

The technological foundation of Arcellx is establishing a new standard for cancer therapy, which strengthens its credit profile. This chart of relative EPS YoY TTM changes on GURU.Markets reflects price stability, with the latest parameter standing at -103.40. Financial resilience is based on management's competence in developing innovations and the neutral geopolitical status of US biotechnologies, which ensures global humanitarian immunity for the business.

This indicator measures the rate of change in net earnings per share over a rolling year, allowing investors to isolate organic business growth from the impact of cheap borrowing. By analyzing the year-over-year EPS growth dynamics over a rolling period, an investor can discern the real efficiency of Arcellx, accounting for capital expenditures on ESG logistics and chemical waste processing within the biopharmaceutical sector.